LYT-510

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameLYT-510
Drug Alias NameOral tacrolimus (PureTech Health)LYT-510
ClassificationSmall molecules > Molecular GlueSmall molecules > Heterocyclic drugs
Mechanisms of ActionBone morphogenetic protein receptor type-2 modulatorsT cell activation inhibitorsCytokines inhibitors +[5] 
TargetsBone morphogenetic protein receptor type-2CytokinesCalcineurin
Therapy Area/IndicationsInflammatory Bowel DiseasesPouchitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPuretech Health
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPureTech Health PLC
Active IndicationsN/A
Inactive IndicationsInflammatory Bowel DiseasesPouchitis

Other Information

ATC CodeN/A
Related LinksN/A